Creative Planning Abb Vie Inc. Call Options Transaction History

Creative Planning

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $43,383 - $49,962	300 New	300 $47,000
Q1 2021 Apr 30, 2021	SELL	$102.3 - $112.62 $61,380 - $67,572	-600 Reduced 40.0%	900 $26,000
Q3 2020 Nov 05, 2020	BUY	$85.91 - $100.83 $77,319 - $90,747	900 Added 150.0%	1,500 $21,000
Q2 2020 Jul 23, 2020	SELL	$73.37 - $98.18 $44,022 - $58,908	-600 Reduced 50.0%	600 $17,000
Q1 2020 May 05, 2020	BUY	$64.5 - $97.79 $38,700 - $58,674	600 Added 100.0%	1,200 $18,000
Q3 2019 Nov 01, 2019	BUY	$62.98 - $75.72 $31,490 - $37,860	500 Added 500.0%	600 $11,000
Q1 2018 Apr 18, 2018	BUY	$92.01 - $123.21 $9,201 - $12,321	100 New	100 $1,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.